View up-to-date information on Horizon Therapeutics Plc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
JP7068231B2 | Grant | CD40L特異的Tn3由来足場およびその使用方法 | A61K38/39; A61K38/39; A61K38/39; A61P1/04; A61P1/04; A61P1/16; A61P1/16; A61P11/00; A61P13/12; A61P15/00; A61P17/00; A61P17/06; A61P17/06; A61P17/14; A61P17/14; A61P19/00; A61P19/02; A61P21/02; A61P21/04; A61P25/00; A61P27/02; A61P27/06; A61P29/00; A61P3/06; A61P3/10; A61P31/04; A61P35/00; A61P37/02; A61P37/06; A61P37/08; A61P5/14; A61P5/38; A61P7/00; A61P7/06; A61P9/00; A61P9/10; C07K14/78; C07K14/78; C07K14/78; C07K16/2875; C07K16/2875; C07K16/2875; C07K2318/20; C07K2318/20; C07K2318/20; C07K2319/21; C07K2319/21; C07K2319/21; C07K2319/30; C07K2319/30; C07K2319/30; C07K2319/31; C07K2319/31; C07K2319/31 | May 16, 2022 |
US20220144940A1 | Application | ILT7 BINDING MOLECULES AND METHODS OF USING THE SAME | A61K2039/505; A61P37/00; C07K16/26; G01N33/564 | May 12, 2022 |
JP7064666B2 | Grant | FcγRIIAに特異的な結合分子及びその使用 | A61K2039/505; A61P1/16; A61P11/00; A61P13/12; A61P17/00; A61P19/02; A61P19/04; A61P21/00; A61P29/00; A61P3/10; A61P31/04; A61P37/00; A61P37/02; A61P37/06; A61P39/02; A61P43/00; A61P7/00; A61P7/04; A61P7/06; A61P9/00; A61P9/10; C07K16/283; C07K2317/24; C07K2317/33; C07K2317/56; C07K2317/565; C07K2317/76; C07K2317/77; C07K2317/92 | May 11, 2022 |
WO2022094334A1 | Application | USE OF AN ANTI-CD19 ANTIBODY TO TREAT AUTOIMMUNE DISEASE | May 05, 2022 | |
US11306145B2 | Grant | Binding molecules specific for Fc?RIIA and uses thereof | A61P7/00; C07K16/283; C07K2317/24; C07K2317/33; C07K2317/565; C07K2317/76; C07K2317/77; C07K2317/92 | April 19, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer